Skip to content
SPARC

SPARC

Vodobatinib (K-0706) is a small molecule which inhibits c-Abl kinase. Its mechanism is focused on inhibiting c-Abl to mitigate neuronal damage and slow the progression of Parkinson’s disease by blocking the effects of harmful signaling in neurons.

Cart 0

Your cart is currently empty.

Start Shopping